CABEI launches its eight issuance in the Swiss Market

The Central American Bank for Economic Integration (CABEI) successfully issued a new fixed rate note with a notional amount of CHF200 million (equivalent to USD196 million), a tenor of 6.5 years and a coupon of 0.371% in the Swiss Market. This transaction is the first in the Swiss market from Latin America and from a Supranational during 2016.

A very volatile market environment in 2016 did not prevent the Multilateral from making a successful transaction in the Swiss market, as it only took one hour to fill the orders and reach a cap set out by CABEI at CHF 200 MM. The large demand (more than 50 accounts participated) allowed a final pricing at the lower bound of the range established as guidance (70-75 over mid-swap), resulting in only 2 basis points of NIC.

Demand came from insurance companies and asset managers mainly and other investors included treasuries, pension funds and private banks.

With this transaction the amount issued by CABEI in the Swiss debt capital markets has reached CHF1,400 million through eight trades executed since 2013, converting it in one of the most important funding sources available to the Multilateral Bank with a 30% participation.

The Executive President of CABEI, Dr. Nick Rischbieth, said: "This transaction once again demonstrates the strong credit perception enjoyed by CABEI among the investor community in Switzerland who always receive the name with great appreciation and interest”:

It is noteworthy that the initiative to diversify markets and financing sources set out in CABEI´s financial strategy has resulted in the placement of bonds in 17 currencies and 20 different markets. CABEI ratings are A1 Stable / A Stable / A Stable (Moody's / S&P / Fitch).

This announcement does not constitute an offer of securities for sale in the United States or in any other jurisdiction in which such an offer would be unlawful.  The securities offered will not be and not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States or outside the United States to, or for the account or benefit of, any U.S. Person, as defined in Regulation S under the Securities Act, absent registration or an applicable exemption from registration requirements.